busulfan has been researched along with Osteopetrosis in 6 studies
Osteopetrosis: Excessive formation of dense trabecular bone leading to pathological fractures; OSTEITIS; SPLENOMEGALY with infarct; ANEMIA; and extramedullary hemopoiesis (HEMATOPOIESIS, EXTRAMEDULLARY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral lorazepam was tolerated by the patients, but all patients needed dose reduction due to some adverse effects." | 1.36 | Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study. ( Amini, M; Ghavamzadeh, A; Hadjibabaie, M; Hamedani, R; Hamidieh, AA; Sadrai, S, 2010) |
| "Infantile malignant osteopetrosis is a fatal disease caused by lack of functional osteoclasts." | 1.35 | Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis. ( Askmyr, M; Ehinger, M; Flores, C; Hjalt, T; Holmberg, J; Richter, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shadur, B | 1 |
| Zaidman, I | 1 |
| NaserEddin, A | 1 |
| Lokshin, E | 1 |
| Hussein, F | 1 |
| Oron, HC | 1 |
| Avni, B | 1 |
| Grisariu, S | 1 |
| Stepensky, P | 1 |
| Behfar, M | 1 |
| Dehghani, SS | 1 |
| Hosseini, AS | 1 |
| Jalali, A | 1 |
| Hamidieh, AA | 2 |
| Ghavamzadeh, A | 2 |
| Naithani, R | 1 |
| Askmyr, M | 1 |
| Holmberg, J | 1 |
| Flores, C | 1 |
| Ehinger, M | 1 |
| Hjalt, T | 1 |
| Richter, J | 1 |
| Hamedani, R | 1 |
| Hadjibabaie, M | 1 |
| Amini, M | 1 |
| Sadrai, S | 1 |
| Slatter, MA | 1 |
| Gennery, AR | 1 |
| Cheetham, TD | 1 |
| Bhattacharya, A | 1 |
| Crooks, BN | 1 |
| Flood, TJ | 1 |
| Cant, AJ | 1 |
| Abinun, M | 1 |
6 other studies available for busulfan and Osteopetrosis
| Article | Year |
|---|---|
Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Female; Follow-Up Studie | 2018 |
Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis.
Topics: Bone Marrow Cells; Busulfan; Child, Preschool; Chimerism; Combined Modality Therapy; Cyclophosphamid | 2015 |
Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide is feasible in bone marrow transplantation for osteopetrosis.
Topics: Busulfan; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Osteopetr | 2015 |
Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis.
Topics: Animals; Animals, Newborn; Blindness; Busulfan; Disease Models, Animal; Hematopoiesis; Humans; Infan | 2009 |
Oral lorazepam prevents seizure during high-dose busulfan in children undergoing hematopoietic stem cell transplantation: a prospective study.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Busulfan; Child; Child, Preschool; Dose-Response | 2010 |
Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
Topics: Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Hy | 2004 |